MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on multiple sclerosis and myasthenia gravis in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with severe autoimmune diseases like multiple sclerosis, neuromyelitis optica, and myasthenia gravis. Up to 1…
Matched conditions: MYASTHENIA GRAVIS
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Wearable tech aims to monitor rare muscle disease
Knowledge-focused Not yet recruitingThis study tests whether wearable sensors can effectively monitor symptoms of myasthenia gravis, a chronic muscle weakness disease. Fifty participants will wear devices that track physical activity, speech, and other health signals over 12 months. The goal is to see if these digi…
Matched conditions: MYASTHENIA GRAVIS
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Massive new study to track brain and nerve autoimmune diseases in real life
Knowledge-focused Not yet recruitingThis study will follow 1,550 adults with various neurological autoimmune diseases—like multiple sclerosis, myasthenia gravis, and autoimmune encephalitis—to see how these conditions progress and respond to treatments in everyday clinical practice. Researchers will collect long-te…
Matched conditions: MYASTHENIA GRAVIS
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC